Incannex Healthcare Inc. (IXHL) Stock

About Incannex Healthcare Inc.

Incannex Healthcare Inc. is led by CEO Joel Bradley Latham, employs 9 people, headquartered in AU, publicly traded since 2022.

Incannex Healthcare Inc. (IXHL) stock trades at $2.64 with a market capitalization of $31.59M. The stock is valued at a negative price-to-earnings (P/E) ratio of -2.87, reflecting a net loss over the last twelve months, price-to-book of 0.59, price-to-sales of 583.72. Over the past 52 weeks the stock has ranged between $2.49 and $14.94, and currently trades 82.3% below its 52-week high.

On profitability, Incannex Healthcare Inc. generates a return on equity (ROE) of -27.42% (negative, reflecting a net loss), return on capital employed of -22.64%, an operating margin of -379.21%.

Incannex Healthcare Inc. by the numbers, 2017–2026

Between 2017 and 2026 Incannex Healthcare Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit rose to $-19.0M.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-64.0M.

Borrowings stand at $0, cash from operations was $-13.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged -166.1% over five years, and was -28.4% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Incannex Healthcare Inc. (IXHL) — frequently asked questions